Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients

BACKGROUND: Secondary hyperparathyroidism (SHPT) is a serious and common complication in patients receiving peritoneal dialysis (PD). Cinacalcet is currently the recommended therapy for SHPT; however, gastrointestinal (GI)-related symptoms can result in low adherence and high discontinuation rates....

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruya, Kazuhiko, Shimazaki, Ryutaro, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586709/
https://www.ncbi.nlm.nih.gov/pubmed/30955188
http://dx.doi.org/10.1007/s10157-019-01692-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586709/
https://www.ncbi.nlm.nih.gov/pubmed/30955188
http://dx.doi.org/10.1007/s10157-019-01692-y

Ejemplares similares